{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T17:45:42Z","timestamp":1769535942702,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03174-6","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:27:47Z","timestamp":1765430867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the synergistic cytotoxicity and apoptosis-inducing effects of eugenol derivatives in combination with docetaxel on PC3 human prostate cancer cells"],"prefix":"10.1007","volume":"43","author":[{"given":"Ghazaleh","family":"Behrouzian Fard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"B. Rassouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Valinezhad Sani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"4","key":"3174_CR1","first-page":"1111","volume":"4","author":"B Bahromov","year":"2025","unstructured":"Bahromov B. Prostate cancer: epidemiology, risk factors, diagnosis. Mod Sci Res. 2025;4(4):1111\u201320.","journal-title":"Mod Sci Res"},{"issue":"2","key":"3174_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, et al. 2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"key":"3174_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/modpathol.2017.158","volume":"31","author":"AJ Evans","year":"2018","unstructured":"Evans AJ. Treatment effects in prostate cancer. Mod Pathol. 2018;31:110\u201321.","journal-title":"Mod Pathol"},{"key":"3174_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-030-52021-2_9","volume-title":"Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider","author":"ML Tsang","year":"2021","unstructured":"Tsang ML. Chemotherapy and Prostate Cancer.Chemotherapy and immunotherapy in urologic oncology: a guide for the advanced practice provider. In: Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider. 2021. p. 105\u201318."},{"issue":"9","key":"3174_CR5","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","volume":"21","author":"K Bukowski","year":"2020","unstructured":"Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21(9):3233.","journal-title":"Int J Mol Sci"},{"key":"3174_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.fitote.2018.02.025","volume":"129","author":"RG de Oliveira J\u00fanior","year":"2018","unstructured":"de Oliveira J\u00fanior RG, et al. Sensitization of tumor cells to chemotherapy by natural products: a systematic review of preclinical data and molecular mechanisms. Fitoterapia. 2018;129:383\u2013400.","journal-title":"Fitoterapia"},{"issue":"23","key":"3174_CR7","doi-asserted-by":"publisher","first-page":"7407","DOI":"10.3390\/molecules26237407","volume":"26","author":"AT Zari","year":"2021","unstructured":"Zari AT, Zari TA, Hakeem KR. Anticancer properties of eugenol: a review. Molecules. 2021;26(23):7407.","journal-title":"Molecules"},{"key":"3174_CR8","doi-asserted-by":"publisher","first-page":"154456","DOI":"10.1016\/j.phymed.2022.154456","volume":"107","author":"SN Begum","year":"2022","unstructured":"Begum SN, Ray AS, Rahaman CH. A comprehensive and systematic review on potential anticancer activities of eugenol: from pre-clinical evidence to molecular mechanisms of action. Phytomedicine. 2022;107:154456.","journal-title":"Phytomedicine"},{"issue":"2","key":"3174_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ddr.21749","volume":"82","author":"SJ Alavi","year":"2021","unstructured":"Alavi SJ, et al. Allylphenols as a new class of human 15-lipoxygenase\u20101 inhibitors. Drug Dev Res. 2021;82(2):259\u201366.","journal-title":"Drug Dev Res"},{"key":"3174_CR10","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00210-019-01689-0","volume":"392","author":"SN Goftari","year":"2019","unstructured":"Goftari SN, et al. Stylosin and some of its synthetic derivatives induce apoptosis in prostate cancer cells as 15-lipoxygenase enzyme inhibitors. Naunyn Schmiedebergs Arch Pharmacol. 2019;392:1491\u2013502.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"15","key":"3174_CR11","first-page":"1722","volume":"23","author":"F Maleki","year":"2023","unstructured":"Maleki F, et al. Investigating the Anti-tumor and Apoptosis-inducing effects of coumarin derivatives as potent 15-Lipoxygenase inhibitors on PC-3 prostate cancer cells. Anti-Cancer Agents Med Chem (Formerly Curr Med Chemistry-Anti-Cancer Agents). 2023;23(15):1722\u201330.","journal-title":"Anti-Cancer Agents Med Chem (Formerly Curr Med Chemistry-Anti-Cancer Agents)"},{"issue":"2","key":"3174_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"T-C Chou","year":"2010","unstructured":"Chou T-C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440\u20136.","journal-title":"Cancer Res"},{"key":"3174_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","volume":"197","author":"AS Doghish","year":"2022","unstructured":"Doghish AS, et al. A review of the biological role of MiRNAs in prostate cancer suppression and progression. Int J Biol Macromol. 2022;197:141\u201356.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"3174_CR14","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3390\/curroncol30020178","volume":"30","author":"CV Berenguer","year":"2023","unstructured":"Berenguer CV, et al. Underlying features of prostate cancer\u2014statistics, risk factors, and emerging methods for its diagnosis. Curr Oncol. 2023;30(2):2300\u201321.","journal-title":"Curr Oncol"},{"key":"3174_CR15","doi-asserted-by":"publisher","first-page":"153303382110119","DOI":"10.1177\/15330338211011965","volume":"20","author":"W Lopez","year":"2021","unstructured":"Lopez W, et al. Ultrasound therapy, chemotherapy and their combination for prostate cancer. Technol Cancer Res Treat. 2021;20:15330338211011965.","journal-title":"Technol Cancer Res Treat"},{"key":"3174_CR16","doi-asserted-by":"publisher","first-page":"991330","DOI":"10.3389\/fcell.2022.991330","volume":"10","author":"S Belkahla","year":"2022","unstructured":"Belkahla S, et al. Advances and development of prostate cancer, treatment, and strategies: A systemic review. Front Cell Dev Biology. 2022;10:991330.","journal-title":"Front Cell Dev Biology"},{"issue":"23","key":"3174_CR17","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"RB Mokhtari","year":"2017","unstructured":"Mokhtari RB, et al. Combination therapy in combating cancer. Oncotarget. 2017;8(23):38022.","journal-title":"Oncotarget"},{"issue":"11","key":"3174_CR18","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/annonc\/mdq050","volume":"21","author":"M Galsky","year":"2010","unstructured":"Galsky M, Vogelzang N. Docetaxel-based combination therapy for castration-resistant prostate cancer. Ann Oncol. 2010;21(11):2135\u201344.","journal-title":"Ann Oncol"},{"issue":"3","key":"3174_CR19","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/cancers15030902","volume":"15","author":"S Sharma","year":"2023","unstructured":"Sharma S, et al. Combination modality using Quercetin to enhance the efficacy of docetaxel in prostate cancer cells. Cancers. 2023;15(3):902.","journal-title":"Cancers"},{"issue":"3","key":"3174_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/biomedicines10030531","volume":"10","author":"S Kamran","year":"2022","unstructured":"Kamran S, et al. Diosmetin exerts synergistic effects in combination with 5-fluorouracil in colorectal cancer cells. Biomedicines. 2022;10(3):531.","journal-title":"Biomedicines"},{"issue":"2","key":"3174_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01635581.2019.1622739","volume":"72","author":"S-J Chen","year":"2020","unstructured":"Chen S-J, et al. Synergistic effect of combined treatment with Longan flower extract and 5-fluorouracil on colorectal cancer cells. Nutr Cancer. 2020;72(2):209\u201317.","journal-title":"Nutr Cancer"},{"key":"3174_CR22","doi-asserted-by":"crossref","unstructured":"Alwan S, Hatem T, Abid H. Molecular mechanisms of eugenol as an antitumour bioactive compound: A comprehensive review. in BIO Web of Conferences. 2024. EDP Sciences.","DOI":"10.1051\/bioconf\/202412503007"},{"key":"3174_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1590\/S0103-50532008000300024","volume":"19","author":"A Carrasco","year":"2008","unstructured":"Carrasco A. Eugenol and its synthetic analogues inhibit cell growth of human cancer cells (part I). J Braz Chem Soc. 2008;19:543\u20138.","journal-title":"J Braz Chem Soc"},{"issue":"1","key":"3174_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/1759-7714.12508","volume":"9","author":"L Fangjun","year":"2018","unstructured":"Fangjun L, Zhijia Y. Tumor suppressive roles of Eugenol in human lung cancer cells. Thorac Cancer. 2018;9(1):25\u20139.","journal-title":"Thorac Cancer"},{"issue":"17","key":"3174_CR25","doi-asserted-by":"publisher","first-page":"9243","DOI":"10.3390\/ijms22179243","volume":"22","author":"ML Abdullah","year":"2021","unstructured":"Abdullah ML, et al. Eugenol-induced autophagy and apoptosis in breast cancer cells via PI3K\/AKT\/FOXO3a pathway Inhibition. Int J Mol Sci. 2021;22(17):9243.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3174_CR26","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1080\/14786419.2022.2103809","volume":"37","author":"MM Alam","year":"2023","unstructured":"Alam MM. Synthesis and anticancer activity of novel Eugenol derivatives against breast cancer cells. Nat Prod Res. 2023;37(10):1632\u201340.","journal-title":"Nat Prod Res"},{"issue":"3","key":"3174_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/mc.22758","volume":"57","author":"SS Islam","year":"2018","unstructured":"Islam SS, et al. Eugenol potentiates cisplatin anti-cancer activity through Inhibition of ALDH\u2010positive breast cancer stem cells and the NF\u2010\u03baB signaling pathway. Mol Carcinog. 2018;57(3):333\u201346.","journal-title":"Mol Carcinog"},{"key":"3174_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1360-3","volume":"38","author":"SS Islam","year":"2019","unstructured":"Islam SS, Aboussekhra A. Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway. J Exp Clin Cancer Res. 2019;38:1\u201314.","journal-title":"J Exp Clin Cancer Res"},{"issue":"21","key":"3174_CR29","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.3390\/molecules24213979","volume":"24","author":"M Fathy","year":"2019","unstructured":"Fathy M, et al. Eugenol exerts apoptotic effect and modulates the sensitivity of HeLa cells to cisplatin and radiation. Molecules. 2019;24(21):3979.","journal-title":"Molecules"},{"issue":"11","key":"3174_CR30","first-page":"5031","volume":"17","author":"J Mohammadian","year":"2016","unstructured":"Mohammadian J, et al. Combined treatment with stattic and docetaxel alters the Bax\/Bcl-2 gene expression ratio in human prostate cancer cells. Asian Pac J Cancer Prev. 2016;17(11):5031\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"3174_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/life13010022","volume":"13","author":"D-A Surducan","year":"2022","unstructured":"Surducan D-A, et al. Eugenol induces apoptosis in tongue squamous carcinoma cells by mediating the expression of Bcl-2 family. Life. 2022;13(1):22.","journal-title":"Life"},{"issue":"1\u20132","key":"3174_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jsbmb.2008.11.002","volume":"113","author":"R Ghosh","year":"2009","unstructured":"Ghosh R, et al. Combination of 2-methoxyestradiol (2-ME2) and Eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol. 2009;113(1\u20132):25\u201335.","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03174-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:50:26Z","timestamp":1769485826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03174-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3174"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03174-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was obtained from the Vice-Chancellor for Research at Mashhad University of Medical Sciences, Mashhad, Iran (Approval Code: [4021123]), ensuring that the study was conducted by ethical principles. This article is original, has not been published before, and is not under review elsewhere. Additionally, the authors confirm that all contributors agree on the order of authorship as listed. All authors have reviewed and approved the final version of the manuscript for submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics, Consent to Participate, and Consent to Publish"}}],"article-number":"41"}}